COMMUNIQUÉS West-GlobeNewswire

La société NGX Bio a réuni 3 millions $ pour financer sa croissance sur le marché du séquençage de l'ADN

16/08/2017 - 01:57

SAN FRANCISCO, le 15 août 2017 (GLOBE NEWSWIRE) - NGX Bio, Inc., ( www.NGXbio.com ), leader du marché dans la prestation de services en ligne dans le domaine du séquençage de l'ADN, a annoncé la finalisation d'une levée [...]

ObsEva Reports Second Quarter 2017 Financial Results and Provides Business Update

15/08/2017 - 22:05

- Patient Enrollment Progressing for late stage clinical programs in Assisted Reproductive Technology, Uterine Fibroids, and Endometriosis - Geneva, Switzerland and Boston, MA - August 15, 2017 - ObsEva SA (NASDAQ: OBSV [...]

Prothena to Present New Research on Cardiac Biomarker NT-proBNP in AL Amyloidosis at HFSA Annual Meeting

15/08/2017 - 22:05

Preclinical Research Demonstrating a Relationship Between Amyloid Light Chain Toxicity and NT-proBNP Production Clinical Outcomes Research Showing a Correlation between NT-proBNP and Health-related Quality of Life [...]

Medtronic to Announce Financial Results for Its First Quarter of Fiscal Year 2018

15/08/2017 - 18:00

DUBLIN - August 15, 2017 - Medtronic plc (NYSE: MDT) announced today that it will report financial results for the first quarter fiscal year 2018 on Tuesday, August 22, 2017. A news release will be issued at [...]

NGX Bio Raises $3 Million to Fund Growth of Its DNA Sequencing Marketplace

15/08/2017 - 17:00

SAN FRANCISCO, Aug. 15, 2017 (GLOBE NEWSWIRE) -- NGX Bio, Inc., ( www.NGXbio.com ) the premier marketplace for online DNA sequencing services, announced it has closed a $3 million funding round. The round was led by 180 [...]

Overallotment option of 15% has been exercised

15/08/2017 - 15:19

Company announcement - No. 37/2017 Overallotment option of 15% has been exercised The 15% overallotment option in connection with Zealand Pharma A/S' initial public offering of American Depositary Shares on the Nasdaq [...]

End of stabilization period

15/08/2017 - 15:17

Company announcement - No. 36/2017 End of stabilization period Zealand Pharma A/S has today received notification regarding the end of the stabilization period Copenhagen, August 15, 2017 - With reference to company [...]

Vascular Dynamics Announces FDA Approval to Initiate CALM 2 Trial for MobiusHD® System for the Treatment of Resistant Hypertension

15/08/2017 - 14:30

MOUNTAIN VIEW, Calif., Aug. 15, 2017 (GLOBE NEWSWIRE) -- Vascular Dynamics, Inc., (VDI) a privately held medical device company developing novel solutions for the treatment of hypertension, today announces that the [...]

Bolton NHS Foundation Trust selects Allscripts to enhance care and clinical engagement

15/08/2017 - 09:00

U.K. Trust launches Allscripts Sunrise(TM) EPR to enable integrated patient record BOLTON, United Kingdom, Aug. 15, 2017 (GLOBE NEWSWIRE) -- Bolton NHS Foundation Trust has selected Allscripts Sunrise Electronic Patient [...]

Curetis Partners with Biotest to support academic PEPPER Pentaglobin® Peritonitis Trial with Unyvero IAI Application

15/08/2017 - 08:13

Curetis Partners with Biotest to support academic PEPPER Pentaglobin ® Peritonitis Trial with Unyvero IAI Application - Trial sponsored by University Clinic RWTH Aachen investigates personalized treatment approaches [...]

Changes in Novo Nordisk Executive Management

15/08/2017 - 08:00

Bagsværd, Denmark, 15 August 2017 - Novo Nordisk A/S today announced two changes to its Executive Management team. As of 1 October, Camilla Sylvest, senior vice president in charge of Novo Nordisk's operations in Region [...]

Immunicum AB (publ) Announces Last Patient Last Visit in the Ongoing Phase I/II Hepatocellular Carcinoma Study

15/08/2017 - 08:00

Press Release 15 August 2017 Immunicum AB (publ) Announces Last Patient Last Visit in the Ongoing Phase I/II Hepatocellular Carcinoma Study Immunicum AB (publ; First North Premier: IMMU.ST), a biopharmaceutical company [...]

Shire announces submission of lifitegrast Marketing Authorization Application for treatment of dry eye disease in Europe

15/08/2017 - 08:00

Shire announces submission of lifitegrast Marketing Authorization Application for treatment of dry eye disease in Europe Lifitegrast, if approved, would be the first and only new class treatment to address the signs and [...]

Nicox annonce une levée de fonds de €26,250 millions

15/08/2017 - 07:30

Communiqué de Presse Nicox annonce une levée de fonds de €26,25 millions 15 août 2017 Sophia Antipolis, France Nicox S.A. (Euronext Paris : FR0013018124, COX, éligible PEA-PME), société internationale spécialisée en [...]

Nicox announces €26.25 million financing

15/08/2017 - 07:30

Press Release Nicox announces €26.25 million financing August 15, 2017 Sophia Antipolis, France Nicox S.A. (Euronext Paris: FR0013018124, COX), the international ophthalmic company, today announced a reserved capital [...]

Taconic Biosciences annonce un partenariat avec Cergentis B.V. pour fournir des services de mappage transgénique

15/08/2017 - 00:23

HUDSON, New York, le 14 août 2017 (GLOBE NEWSWIRE) - Taconic Biosciences, leader mondial en matière de modèles de souris génétiquement modifiés et de services associés, a annoncé qu'elle a signé un accord de [...]

Ossur Hf : Össur hf. initiates a new share buyback program

14/08/2017 - 18:05

Announcement from Össur hf. No. 59/2017 Reykjavík, 14 August 2017 Össur hf. has decided to initiate a new share buyback program (the "Program") tomorrow, 15 August 2017, which will replace the share buyback program that [...]

Ossur Hf : Share buyback program completed

14/08/2017 - 18:00

Announcement from Össur hf. No. 58/2017 Reykjavík, 14 August 2017 On 1 December 2016, Össur hf. initiated a share buy-back program, see Company announcement no. 96/2016. The purpose of the share buyback program was to [...]

Crown Bioscience annonce les résultats du deuxième trimestre et nomme le Dr Yangzhou Wang en qualité de Vice Président senior de Global Operations

14/08/2017 - 17:01

SANTA CLARA, Californie, le 14 août 2017 (GLOBE NEWSWIRE) - Crown Bioscience , filiale en propriété exclusive de Crown Bioscience International (TWSE : symbole boursier 6554) et société internationale de services de [...]